TY - JOUR
T1 - Metro Mapping
T2 - development of an innovative methodology to co-design care paths to support shared decision making in oncology
AU - Stiggelbout, Anne
AU - Griffioen, Ingeborg
AU - Brands, Jasper
AU - Melles, Marijke
AU - Rietjens, Judith
AU - Kunneman, Marleen
AU - Van Der Kolk, Marion
AU - Van Eijck, Casper
AU - Snelders, Dirk
PY - 2023
Y1 - 2023
N2 - Treatment decision-making can be complex, notably when there are multiple treatments available, with different (probabilities of) benefits and harms, for example, survival and side effects.1 It is precisely in these complex situations that the preferences of the patient are of utmost importance, as the trade-offs of benefits and harms are subjective and concern patients' lives.2 In such trade-offs, shared decision making (SDM) has gained momentum as a strategy to include both the best available evidence and the patient's preferences.3
AB - Treatment decision-making can be complex, notably when there are multiple treatments available, with different (probabilities of) benefits and harms, for example, survival and side effects.1 It is precisely in these complex situations that the preferences of the patient are of utmost importance, as the trade-offs of benefits and harms are subjective and concern patients' lives.2 In such trade-offs, shared decision making (SDM) has gained momentum as a strategy to include both the best available evidence and the patient's preferences.3
KW - Clinical Decision-Making
KW - Health Services Research
KW - ONCOLOGY
KW - Patient Care
KW - Quality of Health Care
UR - http://www.scopus.com/inward/record.url?scp=85164515971&partnerID=8YFLogxK
U2 - 10.1136/bmjebm-2022-112168
DO - 10.1136/bmjebm-2022-112168
M3 - Article
C2 - 37236775
AN - SCOPUS:85164515971
SN - 2515-446X
VL - 28
SP - 291
EP - 294
JO - BMJ evidence-based medicine
JF - BMJ evidence-based medicine
IS - 5
M1 - bmjebm-2022-112168
ER -